272 related articles for article (PubMed ID: 27384990)
1. SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells.
Roth M; Wang Z; Chen WY
Oncotarget; 2016 Aug; 7(31):50195-50214. PubMed ID: 27384990
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells.
Wang Z; Yuan H; Roth M; Stark JM; Bhatia R; Chen WY
Oncogene; 2013 Jan; 32(5):589-98. PubMed ID: 22410779
[TBL] [Abstract][Full Text] [Related]
4. KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected].
Yu W; Li L; Wang G; Zhang W; Xu J; Liang A
Cell Physiol Biochem; 2018; 49(6):2111-2123. PubMed ID: 30273928
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair.
Li L; Ye S; Yang M; Yu W; Fan Z; Zhang H; Hu J; Liang A; Zhang W
Oncol Rep; 2015 Dec; 34(6):2935-42. PubMed ID: 26398583
[TBL] [Abstract][Full Text] [Related]
6. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 promotes DNA repair activity and deacetylation of Ku70.
Jeong J; Juhn K; Lee H; Kim SH; Min BH; Lee KM; Cho MH; Park GH; Lee KH
Exp Mol Med; 2007 Feb; 39(1):8-13. PubMed ID: 17334224
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
Chen CS; Wang YC; Yang HC; Huang PH; Kulp SK; Yang CC; Lu YS; Matsuyama S; Chen CY; Chen CS
Cancer Res; 2007 Jun; 67(11):5318-27. PubMed ID: 17545612
[TBL] [Abstract][Full Text] [Related]
9. Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors.
Lee SM; Bae JH; Kim MJ; Lee HS; Lee MK; Chung BS; Kim DW; Kang CD; Kim SH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1084-92. PubMed ID: 17569822
[TBL] [Abstract][Full Text] [Related]
10. Cloning, localization and focus formation at DNA damage sites of canine Ku70.
Koike M; Yutoku Y; Koike A
J Vet Med Sci; 2017 Mar; 79(3):554-561. PubMed ID: 28163277
[TBL] [Abstract][Full Text] [Related]
11. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
[TBL] [Abstract][Full Text] [Related]
12. A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell lines.
Bouley J; Saad L; Grall R; Schellenbauer A; Biard D; Paget V; Morel-Altmeyer S; Guipaud O; Chambon C; Salles B; Maloum K; Merle-Béral H; Chevillard S; Delic J
Oncotarget; 2015 Sep; 6(29):27980-8000. PubMed ID: 26337656
[TBL] [Abstract][Full Text] [Related]
13. Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 (LSD1).
Abdulla A; Zhang Y; Hsu FN; Xiaoli AM; Zhao X; Yang ES; Ji JY; Yang F
J Biol Chem; 2014 Oct; 289(43):29937-47. PubMed ID: 25190802
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
[TBL] [Abstract][Full Text] [Related]
15. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
[TBL] [Abstract][Full Text] [Related]
16. Human Ku70 protein binds hairpin RNA and double stranded DNA through two different sites.
Anisenko AN; Knyazhanskaya ES; Zatsepin TS; Gottikh MB
Biochimie; 2017 Jan; 132():85-93. PubMed ID: 27825805
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
18. ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.
Zang Y; Pascal LE; Zhou Y; Qiu X; Wei L; Ai J; Nelson JB; Zhong M; Xue B; Wang S; Yang D; Lan L; Shan Y; Wang Z
Cancer Lett; 2018 Feb; 415():198-207. PubMed ID: 29179998
[TBL] [Abstract][Full Text] [Related]
19. Skp2 regulates DNA damage repair and apoptosis via interaction with Ku70.
Jia J; Yan D; Wang Y; Liu M; Jia Z; Luo L; Ren J; Fang J; Yuan H; Zhao Y; Song Y; He Y; Wang X
Exp Cell Res; 2020 Dec; 397(1):112335. PubMed ID: 33132134
[TBL] [Abstract][Full Text] [Related]
20. SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity.
Tang M; Chen G; Tu B; Hu Z; Huang Y; DuFort CC; Wan X; Mao Z; Liu Y; Zhu WG; Lu W
Sci Adv; 2023 Jun; 9(24):eade6624. PubMed ID: 37315132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
